Project Grant R01HD115624

Award Date 4/4/25
Completion Date 12/31/29
Dollars Obligated $674K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award of $1,204,928 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the mechanisms by which rare genetic variants in regulatory enhancer regions can cause ectopic gene expression and developmental disorders, using limb malformations as a model. The key objectives of the award are to: 1) characterize the chromatin and...
This $272,125 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the feasibility of genetically targeted therapies for epigenetic neurodevelopmental disorders. The project aims to develop enabling mouse transgenic reagents and conduct proof-of-principle studies to assess the tractability of reinstating expression...
The National Institute of Child Health and Human Development (NICHD) awarded a $364,324 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The grant, effective August 15, 2024 through February 28, 2026, supports research to investigate the role of retrotransposable elements (RTEs) in neurodevelopment and their potential as a therapeutic target for...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a comprehensive atlas of DNA methylation dynamics during key stages of mammalian embryonic development in the mouse. Awarded to Oregon Health & Science University (OHSU), the $654,352 grant will support the production of this rich dataset, capturing DNA methylation profiles at 24-hour intervals...
The Broad Institute, Inc. was awarded a $158,000 Project Grant by the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The award will support the establishment of foundational tools and datasets to investigate the function of the NSD1 gene in neural development. Specifically, the project will generate novel isogenic human induced pluripotent stem cell (iPSC) models of NSD1 haploinsufficiency and assess the dysregulation of histone H3 lysine 36...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research on the developmental origins of Sturge-Weber Syndrome (SWS). The $201,875 award to Duke University aims to address gaps in knowledge about SWS pathogenesis, specifically the timing and cell type of the causative somatic mutation, in order to develop a faithful mouse model of the disease. The...
The National Institute of Child Health and Human Development (NICHD) awarded a $250,120 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to The Trustees of the University of Pennsylvania on August 23, 2024. This grant will support research to investigate the role of a specific histone gene mutation (MACROH2A1) in causing rare pediatric neurodevelopmental disorders. The research aims to 1) characterize the impact of this mutation on human neurodevelopment using...
The National Institute of Child Health and Human Development (NICHD) awarded a $431,750 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Rutgers, The State University of New Jersey, to investigate how the cytokine interleukin-6 (IL-6) affects the proliferation, specification and gene expression of human and mouse secondary neural progenitor cells. The goal is to establish IL-6 as a key target for intervention to prevent neurodevelopmental disorders like...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $160,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to Children's Hospital Medical Center in Cincinnati, Ohio. The grant supports research to investigate the epigenetic mechanisms underlying neurodevelopmental defects in Menke-Hennekam Syndrome, a rare genetic disorder caused by mutations in the EP300 gene. The project aims to (1) identify maturation and...
This $995,880 federal Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Program (CFDA 93.865) will support a multi-disciplinary research project investigating a novel molecular pathway that links protein N-glycosylation in the endoplasmic reticulum to Wnt signaling and regulation of human development. The project aims to delineate the components and mechanisms of this N-glycosylation...

The National Institute of Child Health and Human Development (NICHD) awarded a $674,312 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to The Johns Hopkins University to elucidate the epigenetic mechanisms underlying growth and neurodevelopmental disorders. The research aims to use monogenic syndromes affecting the epigenetic machinery, specifically Weaver and Sotos Syndromes, as models to study the epigenetic regulation of growth and brain development. Key objectives include establishing the neurological phenotype and causal mechanisms in a Weaver Syndrome mouse model, elucidating epigenetic mechanisms of skeletal overgrowth, and comparing epigenetic disease mechanisms and therapeutic responses between Weaver and Sotos Syndrome patient-derived cell models. The project will utilize a cross-species, multi-omics approach to advance the understanding of fundamental epigenetic regulators of growth and neurodevelopment, with the potential to uncover new paradigms and targeted treatments for these rare disorders as well as more common growth and neurological conditions.

Generated 4/29/25, 3:42 AM